India’s drug regulator CDSCO on Thursday reposnded to the World Health Organisation (WHO) that three cough syrups -- Coldrif, RespifreshTR and ReLife -- have been recalled and manufacturers have been ordered to stop their production. The CDSCO has also informed the global health agency that none of the products were exported from India.

Earlier, the WHO had sought to know from Indian authorities whether the cough syrup linked to children deaths in the country was exported to other countries.

The WHO stated that it is closely monitoring recent media reports from India regarding clusters of pediatric illnesses and deaths in Madhya Pradesh and Rajasthan.

These reports, which have emerged during the week of September 29, describe symptoms consistent with acute renal failure and acute enceph

See Full Page